Philip Morris International (PMI) announced a significant milestone, reporting that 41.5% of its total net revenues for the full year 2025 were generated from smoke-free products. This achievement underscores the company's successful strategic transition away from traditional tobacco. Since 2008, PMI has invested over $16 billion in the development and commercialization of these innovative products. The smoke-free portfolio is now available in more than 105 markets globally, serving over 43 million legal-age consumers. PMI remains committed to its vision of a smoke-free future, aiming to eventually end the sale of cigarettes. The company's modified risk tobacco products have also received crucial authorizations from the U.S. FDA, further validating its harm reduction strategy. This strong performance highlights the positive impact of diversification on PMI's business model and future growth prospects.
Get AI-powered deep analysis for every story with a paid subscription
Upgrade for Analysis